Dr. Reddy’s Labs. And RDIF Received approval From DCGI To Conduct Clinical Trial
Hyderabad, Oct.17 (Maxim News): Dr. Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF) today announced that they have received approval from the Drug Control General of India (DCGI) to conduct an adaptive phase 2/3 human…